Clinical Trial Update: GD2-CAR T Cells for Pediatric Brain Tumours [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GD2-CAR T cells for pediatric brain tumors is currently recruiting. The study targets medulloblastoma, embryonal tumors, high-grade gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma
• Embryonal Tumor
• High-grade Glioma
• Medulloblastoma

Drugs mentioned

• GD2-CAR T cells

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Brain Tumor, Pediatric, Medulloblastoma, Childhood | Phase 1 | Status: RECRUITING